2021
DOI: 10.1007/s12519-021-00422-3
|View full text |Cite
|
Sign up to set email alerts
|

Causes of severe neonatal hyperbilirubinemia: a multicenter study of three regions in China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 26 publications
0
5
0
1
Order By: Relevance
“…Term neonates with normal neurologic development and total serum bilirubin <205 μmol/L were recruited as healthy controls. Based on the peak total serum bilirubin level, neonates with hyperbilirubinemia were classified into 3 groups according to previous literature: mildly increased total serum bilirubin group (205 μmol/L < total serum bilirubin < 342 μmol/L, n = 30) 19 ; severely increased TSB group (342 µmol/L ≤ total serum bilirubin < 428 μmol/L, n = 25) 20 ; and extremely increased TSB group (total serum bilirubin ≥ 428 µmol/L, n = 10). 21 Neonates were also divided into an ABE group (n = 29) and a non-ABE group (n = 36) according to the bilirubin-induced neurologic dysfunction (BIND) scale score.…”
Section: Methodsmentioning
confidence: 99%
“…Term neonates with normal neurologic development and total serum bilirubin <205 μmol/L were recruited as healthy controls. Based on the peak total serum bilirubin level, neonates with hyperbilirubinemia were classified into 3 groups according to previous literature: mildly increased total serum bilirubin group (205 μmol/L < total serum bilirubin < 342 μmol/L, n = 30) 19 ; severely increased TSB group (342 µmol/L ≤ total serum bilirubin < 428 μmol/L, n = 25) 20 ; and extremely increased TSB group (total serum bilirubin ≥ 428 µmol/L, n = 10). 21 Neonates were also divided into an ABE group (n = 29) and a non-ABE group (n = 36) according to the bilirubin-induced neurologic dysfunction (BIND) scale score.…”
Section: Methodsmentioning
confidence: 99%
“…Os fatores de risco para a ocorrência dessa patologia são: hipoglicemia, hipercapnia, acidose, hipotermia, hipóxia, infecções bacterianas, hipoalbuminemia, hemólise aguda por Incompatibilidade Rh ou ABO, drogas que competem com a bilirrubina na ligação com a albumina (benzoatos, salicilatos, sulfanomidas, ceftriaxona, ibuprofeno, diuréticos, como furosemida, clorotiazida, ácido etacrínico), irmão antecedente que precisou de Fototerapia, Brazilian Journal of Health Review, Curitiba, v. 6, n. 2, p.5396-5406, mar./apr., 2023 idade gestacional menor que 38 semanas; aleitamento materno exclusivo, mas abaixo do ideal; há cefalohematoma ou hematomas significativos de trauma de nascimento; possui doença hemolítica; ou ainda a mãe é de ascendência do Sudeste Asiático (Vodret, 2018;Salvador, Oliveira, Borges, Vieira & Balestra, 2018;Hamza, 2019;Reddy & Pandey, 2020;Dong, 2021).…”
Section: Metodologiaunclassified
“…BIND arises when unbound bilirubin binds to brain tissue, triggering neurotoxicity ( Bhutani and Johnson, 2009 ). Approximately 1.5% of term and late preterm neonates experiencing substantial hyperbilirubinemia may develop BIND ( Dong et al, 2021 ). Despite its potential as a “never event,” BIND continues to pose a global burden ( Bhutani et al, 2013 ; van der Geest et al, 2022 ).…”
Section: Introductionmentioning
confidence: 99%